Validation studies on the GK+/−ApoE−/− are currently ongoing within our lab to characterize changes in coronary vascular function over time (mice from 6 weeks of age) using ultrasonography and to investigate effect of lipid lowering and standard-of-care treatments for diabetes. The gene discussed is GK; the disease is diabetes mellitus.